- BNF:
- 2.8.2
- Status:
- Grey
- Decision Date:
- November 2012
Comments
GREY: Treatment option on the recommendation of a consultant/specialist after clarity of dosing and monitoring responsibilities.
Grey Drug Classifications
- 2: Lack of data on safety compared with standard therapy
search again